These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 35917078
1. Etiology, urine metabolic risk factors, and urine oxalate patterns in patients with significant hyperoxaluria and recurrent nephrolithiasis. Moore JP, Mauler DJ, Narang GL, Stern KL, Humphreys MR, Keddis MT. Int Urol Nephrol; 2022 Nov; 54(11):2819-2825. PubMed ID: 35917078 [Abstract] [Full Text] [Related]
2. Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria. D'Costa MR, Kausz AT, Carroll KJ, Ingimarsson JP, Enders FT, Mara KC, Mehta RA, Lieske JC. Nephrol Dial Transplant; 2021 Dec 02; 36(12):2208-2215. PubMed ID: 33367720 [Abstract] [Full Text] [Related]
5. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease. Perinpam M, Enders FT, Mara KC, Vaughan LE, Mehta RA, Voskoboev N, Milliner DS, Lieske JC. Clin Biochem; 2017 Dec 02; 50(18):1014-1019. PubMed ID: 28764885 [Abstract] [Full Text] [Related]
6. Diet-related urine collections: assistance in categorization of hyperoxaluria. Dill H, Martin-Higueras C, Hoppe B. Urolithiasis; 2022 Apr 02; 50(2):141-148. PubMed ID: 34821949 [Abstract] [Full Text] [Related]
7. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers. Otto BJ, Bozorgmehri S, Kuo J, Canales M, Bird VG, Canales B. J Endourol; 2017 Dec 02; 31(12):1335-1341. PubMed ID: 29084490 [Abstract] [Full Text] [Related]
8. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Nelson WK, Houghton SG, Milliner DS, Lieske JC, Sarr MG. Surg Obes Relat Dis; 2005 Dec 02; 1(5):481-5. PubMed ID: 16925274 [Abstract] [Full Text] [Related]
10. What treatments reduce kidney stone risk in patients with bowel disease? Bianco J, Chu F, Bergsland K, Coe F, Worcester E, Prochaska M. Urolithiasis; 2022 Oct 02; 50(5):557-565. PubMed ID: 35976425 [Abstract] [Full Text] [Related]
11. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group. Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027 [Abstract] [Full Text] [Related]
14. Dietary management of idiopathic hyperoxaluria and the influence of patient characteristics and compliance. Schwen ZR, Riley JM, Shilo Y, Averch TD. Urology; 2013 Dec 07; 82(6):1220-5. PubMed ID: 24054440 [Abstract] [Full Text] [Related]
15. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. Asplin JR, Coe FL. J Urol; 2007 Feb 07; 177(2):565-9. PubMed ID: 17222634 [Abstract] [Full Text] [Related]
18. Use of a probiotic to decrease enteric hyperoxaluria. Lieske JC, Goldfarb DS, De Simone C, Regnier C. Kidney Int; 2005 Sep 07; 68(3):1244-9. PubMed ID: 16105057 [Abstract] [Full Text] [Related]
19. Oxalate status in stone-formers. Two distinct hyperoxaluric entities. Hatch M. Urol Res; 1993 Jan 07; 21(1):55-9. PubMed ID: 8456539 [Abstract] [Full Text] [Related]
20. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. Duffey BG, Pedro RN, Makhlouf A, Kriedberg C, Stessman M, Hinck B, Ikramuddin S, Kellogg T, Slusarek B, Monga M. J Am Coll Surg; 2008 Jun 07; 206(6):1145-53. PubMed ID: 18501812 [Abstract] [Full Text] [Related] Page: [Next] [New Search]